本院应用自身菌苗预防以感染为主要激发因素的支气管哮喘患者有显著效果,已另有专题报告,但鉴于自身菌苗必须采取自身细菌后各别制备,操作既不便,费用又贵,因此自1963年初到1964年底的二年内,改用呼吸道常见细菌制成贮存菌苗(Srock Vaccine)预防105例以呼吸道感染为主要激发因素的哮喘患者,兹总结防治经验并报导于下: Our hospital has its own bacterins to prevent infection as the main motivating factor in patients with bronchial asthma have a significant effect, there are other special reports, but in view of their own vaccine must take their own bacteria after the preparation, the operation is not easy, expensive and therefore From the beginning of 1963 to the end of 1964, the switch to the use of common respiratory bacteria as a storage vaccine (Srock Vaccine) to prevent 105 cases of asthma patients with respiratory tract infection as the main motivating factor, we sum up the experience of prevention and control and reported the following: